Cardiology

Top Story

BRAVO 3: Outcomes after transfemoral TAVR do not vary by sex

May 6, 2016

ORLANDO, Fla. — In the BRAVO 3 study population of patients undergoing transfemoral transcatheter aortic valve replacement, outcomes did not differ between men and women, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

This is the first contemporary TAVR study that did not show a higher rate of major vascular complications for women than for men, likely because newer-generation TAVR systems with smaller sheaths were commonly used, and the study included TAVR procedures via transfemoral access only, Anita W. Asgar, MD, interventional cardiologist at Montreal Heart Institute, said during a presentation. 

Meeting News CoverageVideo

VIDEO: Moderate sedation shows promise for patients undergoing TAVR

May 6, 2016
ORLANDO, Fla. — In this video, Jay S. Giri, MD, MPH, discusses a “minimalist” approach to transfemoral transcatheter aortic valve replacement.At the…
Meeting News CoverageVideo

VIDEO: Michael R. Gold, MD, PhD, highlights groundbreaking trials at HRS 2016

May 6, 2016
SAN FRANCISCO — New data presented at the Heart Rhythm Society Annual Scientific Sessions advance the understanding of catheter ablation and cardiac…
Meeting News Coverage

Severe sleep apnea associated with higher risk for AF in patients with pacemakers

May 6, 2016
SAN FRANCISCO — In patients with pacemakers, severe sleep apnea was a significant predictor of atrial fibrillation, according to a study presented at Heart Rhythm…
Meeting News Coverage

COAST: Next-generation orbital atherectomy system benefits patients with severely calcified lesions

May 6, 2016
ORLANDO, Fla. — A next-generation orbital atherectomy system was effective at treating severely calcified coronary lesions, according to results from the COAST…
More News Headlines »
CME

Cardiovascular Event Reduction: A Closer Look at Secondary Prevention in 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The prevention of thrombotic cardiovascular disease–the leading cause of morbidity and mortality in the United…
More »
Video
Meeting News Coverage

VIDEO: LAA occlusion device safe, effective in regulatory study

May 2, 2016
More »
Featured
Highlights from ACC Scientific Session

Highlights from ACC Scientific Session

Video
Meeting News Coverage

VIDEO: Expert discusses results from HOPE-3 trial

April 27, 2016
More »
morganatic-roan